Environmental Stewardship

At a Glance

Global Environmental Management Principles

Mylan’s Global EHS Management System is based on companywide principles that provide a framework of performance expectations with respect to our employees and external partners. Our technical standards establish global minimum operating requirements for a variety of safety and environmental activities. Implementing these standards helps ensure compliance with applicable regulations in the countries where we operate, in addition to filling gaps where certain regulations may not exist and driving continuous improvement.

We monitor and track many elements of our environmental performance allowing us to manage data, oversee results and identify risks and opportunities. We routinely conduct assessments and on-site audits, including reviews of our data, systems and programs.

Conserving Water and Managing Wastewater

We work diligently to practice responsible water management and protect this precious resource. Our highly regulated industry often presents restrictions and limitations related to items such as reuse of water in production. Production requirements of our operations – coupled with local regulations and infrastructure – guide the type of water and wastewater management systems and processes we utilize. Due to these requirements, a significant amount of water is rejected as part of the purification processes and is discharged as wastewater. Wastewater from all of Mylan’s operations undergoes treatment prior to discharge to the environment, and in India, multiple sites apply zero liquid discharge (ZLD) technology that eliminates discharge. Please read our 2018 GSR Report for additional information.

Water Use by Sources (thousand m3) 2015 2016 2017 2018
Municipal / Third party 3,016 3,056 3,148 3,179
On-site borewell 73 73 89 112
Rainwater 2 2 2 2
Other 5 5 5 5
Water Use & Discharge Summary (thousand m3) 2015 2016 2017 2018
Total water supply 3,096 3,136 3,244 3,299
Total water recycled and reused 133 370 424 467
Total water discharged 1,669 1,613 1,616 1,554
Sites with zero liquid discharge (ZLD) systems 6 7 9 10

Minimizing Pharmaceuticals in the Environment

As a pharmaceutical company and member of the global community, Mylan is committed to caring for the environment and promoting responsible manufacturing by taking steps to minimize the environmental impact of our operations and products, while also balancing our need to produce high quality, life-saving medication.

The primary pathways for pharmaceuticals entering the environment from human use are by normal patient excretion and improper disposal of medicine by consumers,1 in addition to the use of pharmaceuticals in agriculture. A significantly smaller contribution stems from emissions resulting from the pharmaceutical manufacturing process, which is attributed to less than 2% of the overall contribution.2

While gaps remain in the scientific link between pharmaceuticals in the environment and human health risk, we are committed to reducing pharmaceuticals discharged from our manufacturing operations.

Mylan’s approach to addressing and minimizing the potential impact of PiE from our own manufacturing is based on a wide range of activities and governance including:

We are a member of the AMR Industry Alliance. All member companies are committed to addressing AMR across four key areas: research, appropriate use, access and manufacturing and the environment. Mylan participates in their manufacturing working group and supports the Common Antibiotic Manufacturing Framework.

1Caldwell, D.J. (2015) Sources of Pharmaceutical Residues in the Environment and their Control, from ‘Pharmaceuticals in the Environment’, 2015, 92- 119 Editor(s): R E Hester, R M Harrison. Royal Society of Chemistry, London, UK.

2BIO Intelligence Service (2013), Study on the environmental risks of medicinal products, final report prepared for Executive Agency for Health and Consumers, pp. 46-47.

Climate Change and Energy

Responsible Energy Management

We continuously evaluate and identify opportunities to lower our energy demand usage and decrease GHG emissions. As part of our work to support responsible manufacturing efforts, the U.N. Global Compact and SDG 13, we work to reduce our absolute total GHG emissions (Scope 1 and 2).

Many of our sites completed energy management projects in 2018, such as making equipment improvements, installing LED lighting and purchasing renewable energy. We also identified opportunities to phase out certain ozone-depleting substance (ODS) refrigerants.

  • Eight sites globally are certified to the 50001 ISO Energy Management standard; and
  • In 2018, we purchased 72 million kilowatt hours of renewable energy from local renewable energy suppliers, an increase of approximately 30% since 2017.

CDP Supporter

We disclose our performance through the CDP Climate Change Program and in 2018 increased our engagement as an official CDP Supporter. Our 2015-2017 GHG emissions data were verified by a third party. We have applied the same data validation approach for reporting to CDP for 2018 data.

Greenhouse Gas Emissions (thousand tonnes CO2e) 2015 2016 2017 2018
Total GHG Emissions 706 714 727 734
Scope 1 GHG emissions 370 388 402 402
Scope 2 GHG emissions (market-based) 336 326 325 332
Total GHG Emissions Intensity Ratio (tonnes CO2e / million USD revenue) 75 65 61 64

Reducing Waste

In all our operations, we are committed to reducing waste through responsible use of resources, increased recycling, reuse of materials and initiatives dedicated to waste minimization. Across our sites in 2018, we recycled, reused or repurposed 26% of total waste generated and 44% was sent to various energy recovery facilities. Ninety-five percent of our pharmaceutical waste is diverted from landfill to incineration or energy recovery facilities.

We continue to strive to reduce or eliminate the amount of waste sent to landfills and are looking to increase the number of zero landfill sites. We encourage our patients and consumers to dispose of unused or expired products or waste materials in accordance with local regulatory requirements.

Decreasing Air Emissions

We use new technology as it becomes available. Examples include high-efficiency dust collection, HEPA filtration, electrostatic precipitation, primary and secondary condensers, multi-stage filtration and recirculation systems, process scrubber technology and regenerative thermal oxidizers.